Cardiolyse was chosen as one of the 40 most promising digital healthcare startups in Europe to participate in the 8th edition of the Healthtech Summit in Lausanne 26-28 June.
Wlodek Laskowski, our CFO, presented Cardiolyse to the leading investors and industry partners. “It was an inspiring event and highly productive three days. At Cardiolyse we were delighted to be among the most talented Healthcare teams in Europe. It was also extremely encouraging to see the top-level VC funds being highly interested in the opportunities of CVD prevention market.”
Cardiolyse’s ultimate goal is to enable heart health self-management, which will empower people to extend their independent and healthy life until 60 years and beyond.
Cardiolyse markets B2B Saas HRV and ECG processing platform with Heart and Emotional Wellbeing predictive score. It provides:
- sophisticated ECG analysis,
- individual ECG and HRV baselines as well as
- personalised recommendations.
Therefore, it enables creating personalised ideal lifestyle. To put it another way, it helps to create habits that fit each user individually to prolong healthy lifetime and to retard cardiovascular ageing for people in their 40s-60s to slow down health deterioration in general.
Our vision is to be an essential part of the population health monitoring and prevention, providing the best prognostic tools for managing heart health and leading the prevention of CVDs.
The Healthtech Summit is the leading independent European platform for investment in Digital Health and Medtech since its 1st edition in 2008 and is organised by Tech Tour. Venture Capitalist Sven Lingjaerde founded the Tech Tour in 1998. As of 2013, the Tech Tour is collaborating with the International Venture Club (IVC) and Europe Unlimited on all events and activities.